Injectable suspension of allogeneic adult mesenchymal stem cells
HidraQureS/2020
Phase 2 mab active
Quick answer
Injectable suspension of allogeneic adult mesenchymal stem cells for Hidradenitis Suppurativa is a Phase 2 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Hidradenitis Suppurativa
- Phase
- Phase 2
- Modality
- mab
- Status
- active